{{Drugbox
| IUPAC_name               = (±)-6-(dimethylamino)-5-methyl-4,4-diphenyl-3-hexanone
| image                    = Isomethadone structure.svg
| width                    = 201
| CAS_number               = 466-40-0
| CAS_supplemental         = <br />5341-49-1 ([[hydrochloride|HCl]])<br />26594-41-2 ((''R'')-form)<br />561-10-4 ((''S'')-form)<br />7484-81-2 ((''S'')-form (HCl))
| ATC_prefix               = None
| ATC_suffix               = 
| PubChem                  = 10072
| ChemSpiderID             = 9675
| C=21 | H=27 | N=1 | O=1
| molecular_weight         = 309.445 g/mol
| smiles                   = O=C(CC)C(C1=CC=CC=C1)(C(C)CN(C)C)C2=CC=CC=C2
| synonyms                 = WIN-1783, BW 47-442
| StdInChI                 = 1S/C21H27NO/c1-5-20(23)21(17(2)16-22(3)4,18-12-8-6-9-13-18)19-14-10-7-11-15-19/h6-15,17H,5,16H2,1-4H3
| StdInChIKey              = IFKPLJWIEQBPGG-UHFFFAOYSA-N
| bioavailability          = 
| protein_bound            = 
| metabolism               = 
| elimination_half-life    = 
| excretion                = 
| pregnancy_category       = 
| legal_DE = Anlage II
| legal_status             = 
| legal_AU                 = S9
| legal_CA = Schedule I
| legal_US                 = Schedule II
|legal_UN = P I
| routes_of_administration = 
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 12L95QD6KV
}}

'''Isomethadone''' ([[International Nonproprietary Name|INN]], [[British Approved Name|BAN]]; '''Liden'''), also known as '''isoamidone''', is a [[Chemical synthesis|synthetic]] [[opioid]] [[analgesic]] and [[antitussive]] related to [[methadone]] that was used formerly as a [[pharmaceutical]] [[drug]] but is now no longer marketed.<ref name="Macdonald1997">{{cite book | author = F.. Macdonald | title = Dictionary of Pharmacological Agents | url = https://books.google.com/books?id=A0THacd46ZsC&pg=PA1169 | accessdate = 16 May 2012 | year = 1997 | publisher = CRC Press | isbn = 978-0-412-46630-4 | page = 1169}}</ref><ref name="MortonMorton1999">{{cite book | author1 = Dr. Ian Morton | author2 = Ian K. M. Morton | author3 = Judith M. Hall | author4= Dr. Judith Hall | title = Concise Dictionary of Pharmacological Agents: Properties and Synonyms | url = https://books.google.com/books?id=mqaOMOtk61IC&pg=PA157 | accessdate = 16 May 2012 | year = 1999 | publisher = Springer | isbn = 978-0-7514-0499-9 | page = 157}}</ref><ref name="pmid14928215">{{cite journal |vauthors=KEATS AS, BEECHER HK | title = Analgesic potency and side action liability in man of heptazone, WIN 1161-2, 6-methyl dihydromorphine, Metopon, levo-isomethadone and pentobarbital sodium, as a further effort to refine methods of evaluation of analgesic drugs | journal = The Journal of Pharmacology and Experimental Therapeutics | volume = 105 | issue = 2 | pages = 109–29 |date=June 1952 | pmid = 14928215 | doi = | url = http://jpet.aspetjournals.org/cgi/pmidlookup?view=long&pmid=14928215}}</ref><ref name="pmid13027341">{{cite journal |vauthors=WINTER CA, FLATAKER L | title = Antitussive action of d-isomethadone and d-methadone in dogs | journal = Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) | volume = 81 | issue = 2 | pages = 463–5 |date=November 1952 | pmid = 13027341 | doi = 10.3181/00379727-81-19912| url = }}</ref> Isomethadone was used as both an [[analgesic]] and [[antitussive]]. It binds to and activates both the [[μ-opioid receptor|μ-]] and [[δ-opioid receptor]]s, with the (''S'')-[[isomer]] being the more [[potency (pharmacology)|potent]] of its two [[enantiomer]]s.<ref name="pmid6284938">{{cite journal  |vauthors=Portoghese PS, Poupaert JH, Larson DL, etal | title = Synthesis, X-ray crystallographic determination, and opioid activity of erythro-5-methylmethadone enantiomers. Evidence which suggests that mu and delta opioid receptors possess different stereochemical requirements | journal = Journal of Medicinal Chemistry | volume = 25 | issue = 6 | pages = 684–8 |date=June 1982 | pmid = 6284938 | doi = 10.1021/jm00348a015| url = }}</ref> Isomethadone is a [[Controlled Substances Act#Schedule II controlled substances|Schedule II]] [[controlled substance]] in the [[United States]], with an ACSCN of 9226 and a 2014 aggregate manufacturing quota of 5 grammes.  The salts in use are the hydrobromide (free base conversion ratio 0.793), hydrochloride (0.894), and HCl monohydrate (0.850).<ref>http://www.deadiversion.usdoj.gov/fed_regs/quotas/2014/fr0825.htm</ref> Isomethadone is also regulated [[international]]ly as a [[Single Convention on Narcotic Drugs#Schedules of drugs|Schedule I]] controlled substance under the [[United Nations]] [[Single Convention on Narcotic Drugs]] of 1961.<ref name="Nordegren2002">{{cite book | author = Thomas Nordegren | title = The A-Z Encyclopedia of Alcohol and Drug Abuse | url = https://books.google.com/books?id=4yaGePenGKgC&pg=PA366 | accessdate = 16 May 2012 | date = 1 March 2002 | publisher = Universal-Publishers | isbn = 978-1-58112-404-0 | page = 366}}</ref>

== See also ==
* [[Methadone]]

== References ==
{{reflist|30em}}

{{Analgesics}}
{{Antitussives}}
{{Opioidergics}}

[[Category:Amines]]
[[Category:Analgesics]]
[[Category:Antitussives]]
[[Category:Delta-opioid agonists]]
[[Category:Ketones]]
[[Category:Mu-opioid agonists]]
[[Category:Synthetic opioids]]


{{analgesic-stub}}